This page lists the surgical oncology hospitals in our directory offering Gallbladder Cancer Treatment in Hyderabad, India, including KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills. Each listing links through to the hospital's full profile page.
Ask us about gallbladder cancer treatment in Hyderabad, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 4 accredited hospitals for Surgical Oncology in Hyderabad, India
🇮🇳 KIMS Hospitals, Secunderabad
🇮🇳 Yashoda Hospitals, Secunderabad
🇮🇳 Apollo Hospital DRDO
🇮🇳 Apollo Hospitals, Jubilee Hills
How we selected these hospitals
A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Gallbladder Cancer Treatment in Hyderabad, India?
Choosing the right hospital for gallbladder cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include surgical oncology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Gallbladder Cancer Treatment
Gallbladder cancer is a rare but aggressive malignancy requiring precise, multidisciplinary oncological care — from radical cholecystectomy and extended hepatic resection to adjuvant chemotherapy with gemcitabine-cisplatin regimens and targeted immunotherapy. With 5-year survival rates ranging from 15% to 80% depending on staging, early and expert intervention is critical. GAF Healthcare connects international patients with India's and the UAE's leading JCI- and NABH/DHA-accredited cancer centres, where high-volume hepatobiliary oncology teams deliver globally benchmarked outcomes at a fraction of Western costs.
Clinical Overview
Gallbladder cancer (GBC) is an epithelial malignancy arising from the mucosal lining of the gallbladder, with adenocarcinoma accounting for over 90% of cases. It is the most common biliary tract cancer globally, with disproportionately high incidence in South Asia, Latin America, and Eastern Europe. The gallbladder's thin walls and proximity to the liver (segment IV–V), bile ducts, portal vasculature, and regional lymphatics mean that even early-stage tumours can invade adjacent structures, making anatomical staging — using the AJCC/TNM 8th Edition classification — and radiological precision essential to treatment planning. Physiologically, the disease frequently presents late due to the gallbladder's lack of a serosal layer on its hepatic surface, allowing direct hepatic extension without peritoneal dissemination, and its rich lymphatic drainage accelerating nodal spread.
Full details →Who is a Candidate?
- ELIGIBLE FOR SURGICAL RESECTION:
- Histologically confirmed gallbladder carcinoma (adenocarcinoma, papillary, mucinous variants) staged T1b to T3 (AJCC 8th Edition)
- ECOG performance status 0–2
- Adequate hepatic reserve: future liver remnant (FLR) ≥30% of total functional liver volume (assessed by CT volumetry)
- No distant metastases (M0) on staging workup
- +22 more
Treatment Options & Approaches
Surgical APPROACHES:
1. SIMPLE CHOLECYSTECTOMY (T1a only): Acceptable for incidental T1a tumours confined to the lamina propria with clear margins on frozen section. Laparoscopic technique is standard. No re-resection required.
2. RADICAL CHOLECYSTECTOMY WITH HEPATIC RESECTION (T1b–T3, primary standard): En-bloc resection of the gallbladder with a 2–3 cm margin of hepatic parenchyma involving segments IVb and V. Accompanied by systematic lymphadenectomy of the hepatoduodenal ligament (portal hepatis), including pericholedochal, cystic duct, right hepatic artery, and anterior/posterior portal vein nodes (minimum 6 nodes for adequate staging). Bile duct excision with Roux-en-Y hepaticojejunostomy reconstruction is added when bile duct margin involvement is confirmed on frozen section or when achieving a clear cystic duct margin is not feasible.
3. EXTENDED HEPATIC RESECTION (T3–T4 with vascular or extensive hepatic involvement): Right hepatectomy or right trisectionectomy may be required for advanced local disease. Portal vein embolisation (PVE) is performed 4–6 weeks pre-operatively when FLR is inadequate (<30%). In selected centres, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is employed.
Full details →Recovery
PHASE 1 — PRE-TRAVEL WORKUP (2–4 weeks before departure):
- Patient submits medical records to GAF Healthcare case manager: histopathology, imaging (CT/MRI/PET-CT), blood reports, operative reports if prior cholecystectomy
- GAF connects patient with assigned hepatobiliary oncology team at chosen centre (India or UAE)
- Telemedicine consultation conducted: tumour board review, resectability assessment, staging confirmation, NGS report review
- Travel plan confirmed: visa category arranged (e-Medical Visa for India; visit/medical visa for UAE), treatment dates locked
- Insurance pre-authorisation initiated where applicable
PHASE 2 — ARRIVAL & PRE-OPERATIVE EVALUATION (Days 1–3 in-country):
Full details →Risks to be aware of
Gallbladder cancer surgery, particularly when involving extended hepatic resection and biliary reconstruction, carries a defined spectrum of perioperative and oncological risks that patients must understand before travel. Perioperative mortality at high-volume HPB centres ranges from 1–3% for standard radical cholecystectomy and up to 5–8% for major hepatectomy, with rates significantly lower at centres performing >20 hepatobiliary resections per month. The most significant surgical complication is post-hepatectomy liver failure (PHLF), graded using the ISGLS criteria, occurring in 5–10% of cases involving resection of >60% of hepatic parenchyma — mitigated by pre-operative FLR volumetry and portal vein embolisation when indicated. Bile leak (ISGLS Grade B/C) occurs in 5–15% of cases, typically managed conservatively with drain maintenance or radiological/endoscopic intervention. Post-operative haemorrhage requiring re-exploration occurs in 1–3% of patients. Hepaticojejunostomy anastomotic stricture is a delayed complication (6–24 months post-operatively) occurring in approximately 3–8% of reconstructed cases, managed with endoscopic balloon dilation or percutaneous interventions. Systemic chemotherapy with gemcitabine-cisplatin carries well-documented risks of myelosuppression (Grade 3/4 neutropaenia in 25–30%), nephrotoxicity (managed with vigorous pre-hydration), and peripheral neuropathy. Durvalumab and other checkpoint inhibitors carry immune-related adverse events (irAEs), including immune-mediated hepatitis (Grade ≥3 in 3–5%), colitis, and pneumonitis, requiring early recognition and corticosteroid management. Oncologically, even R0 resections carry substantial recurrence risk: approximately 60–70% of patients develop locoregional or distant recurrence within 2 years, emphasising the importance of structured adjuvant therapy and surveillance imaging (CT/MRI every 3–6 months for 2 years). Patients with bile spillage during prior laparoscopic cholecystectomy face elevated risk of peritoneal seeding; port-site excision is recommended and outcomes in this subgroup are generally poorer. GAF Healthcare ensures patients receive complete risk stratification, pre-operative optimisation, and written informed consent documentation from their treating HPB oncologist before committing to travel.
Why GAF Healthcare
GAF Healthcare provides end-to-end non-medical coordination for gallbladder cancer patients travelling to India or the UAE, ensuring the treatment experience is seamless from the moment of enquiry to post-discharge follow-up.
Common questions about Gallbladder Cancer Treatment
What is the cost of Gallbladder Cancer Treatment in India versus the UAE?
How long do I need to stay in the country before I am fit to fly home after Gallbladder Cancer Treatment?
What is the success rate of Gallbladder Cancer Treatment?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Gallbladder Cancer Treatment in Hyderabad, India
Discover the Top Hospitals for Gallbladder Cancer Treatment in Hyderabad, India
This page lists 4 accredited surgical oncology hospitals in Hyderabad, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about gallbladder cancer treatment in Hyderabad, India
How many surgical oncology hospitals are listed in Hyderabad, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there surgical oncology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for gallbladder cancer treatment in Hyderabad, India.
Contact us to report an inaccuracy on this page.